Conrig Pharma ApS engages in development of drug for oral treatment of atopical dermatitis
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Jyderup
State: Sjelland
Zip:
Country: Denmark
Conrig Pharma will reposition drug molecules with attractive safety and efficacy profiles through simple modifications and reformulations to provide fast development of new treatments of illnesses. Initial focus will be on a development of a new drug for oral treatment of atopic dermatitis (a type of eczema).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2010 | Venture Round | 1 | - |
Seed Capital Seed Capital |
3/2013 | Venture Round | 1 | - |
Seed Capital Seed Capital |
3/2013 | Venture Round | 1 | - |
Seed Capital Seed Capital |
11/2010 | Venture Round | 1 | - |
Seed Capital Seed Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|